Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Treibacher Industrie AG is a global leader in chemistry and metallurgy, specializing in high-performance materials for diverse industrial and medical applications. Founded in 1898 by Carl Auer von Welsbach, the company provides critical high-purity chemical precursors and powders used in dental ceramics, orthopedic implants, and medical imaging contrast agents. Their healthcare portfolio includes rare earth compounds such as gadolinium for MRI contrast media and zirconium-based materials for restorative dentistry. Headquartered in Austria, Treibacher operates as a key supplier and contract manufacturer for the global life sciences and medical technology sectors. The company is recognized for its expertise in rare earth processing and its ability to meet stringent quality standards for pharmaceutical and medical-grade materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Treibacher Industrie.